TP53 and diffuse large B-cell lymphoma: As expected, mutations in MYC, ID3 and CCND3 were more frequent in Burkitt Lymphoma than in DLBCL or follicular lymphoma, and additionally we also detected the significant enrichments of Burkitt Lymphomas in TP53 and FBXO11 mutations.